AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios

AD Metabolomics Consortium Phenomenome Phosphatidylcholine (PtdCho), Lysophosphatidylcholine (LPtdCho), Sphingomyeline (SM) Flow Injection Positive Ionization LC-MS/MS Internal Standard Ratios

data(admcpdipesipcisratios)

Format

A data frame with 829 rows and 36 variables

Details

A dataset with variables as follows:

  • RID -4 -4 Participant roster ID

  • RECNO -4 -4 Record number (2 indicates replicate sample)

  • PC.34.3 -4 -4 diacyl-PtdCho 16:0/18:3; 14:0/20:3; 16:1/18:2

  • PC.34.0 -4 -4 diacyl-PtdCho 16:0/18:0; 14:0/20:0

  • PC.34.1 -4 -4 diacyl PtdCho 16:0/18:1; 14:0/20:1; 16:1/18:0

  • PC.34.2 -4 -4 diacyl PtdCho 16:0/18:2; 14:0/20:2; 16:1/18:1

  • PC.36.4 -4 -4 diacyl PtdCho 16:0/20:4; 18:1/18:3; 14:0/22:4; 18:2/18:2; 16:1/20:3

  • PC.36.5 -4 -4 diacyl PtdCho 16:0/20:5; 14:0/22:5; 18:2/18:3; 18:2/18:3

  • PC.38.4 -4 -4 diacyl PtdCho 16:0/22:4, 18:0/20:4; 14:0/24:4; 18:1/20:3

  • PC.38.6 -4 -4 diacyl PtdCho 16:0/22:6, 18:1/20:5; 14:0/24:6; 18:2/20:4

  • PC.38.7 -4 -4 diacyl PtdCho 16:1/22:6; 14:1/24:6; 18:2/20:5

  • PC.36.2 -4 -4 diacyl PtdCho 18:0/18:2; 18:1/18:1; 14:0/22:2; 16:0/20:2; 16:1/20:1

  • PC.36.3 -4 -4 diacyl PtdCho 18:0/18:3, 18:1/18:2; 14:0/22:3; 16:0/20:3; 16:1/20:2

  • PC.38.5 -4 -4 diacyl PtdCho 18:0/20:5, 18:1/20:4; 14:0/24:5; 16:0/22:5; 16:1/22:4

  • PC.40.4 -4 -4 diacyl PtdCho 18:0/22:4; 16:0/24:4; 16:1/24:3; 20:0/20:4

  • PC.40.6 -4 -4 diacyl PtdCho 18:0/22:6; 16:0/24:6; 18:1/22:5

  • PC.40.5 -4 -4 diacyl PtdCho 18:1/22:4; 16:0/24:5; 18:0/22:5; 20:0/20:5; 20:1/20:4

  • PC.40.7 -4 -4 diacyl PtdCho 18:1/22:6; 16:0/24:6

  • PC.36.6 -4 -4 diacyl PtdCho 14:0/22:6; 16:1/20:5; 18:3/18:3

  • PC.38.0 -4 -4 diacyl PtdCho 18:0/20:0;16:0/22:0

  • PC.40.1 -4 -4 diacyl PtdCho 18:0/22:1; 18:1/22:0; 16:0/24:1; 16:1/24:0

  • PC.40.2 -4 -4 diacyl PtdCho 18:1/22:1; 18:0/22:2; 16:0/24:2; 16:1/24:1

  • LPC.16.0 -4 -4 LPtdCho 16:0/OH

  • LPC.16.1 -4 -4 LPtdCho 16:1/OH

  • LPC.18.0 -4 -4 LPtdCho 18:0/OH

  • LPC.18.1 -4 -4 LPtdCho 18:1/OH

  • LPC.18.2 -4 -4 LPtdCho 18:2/OH

  • LPC.20.4 -4 -4 LPtdCho 20:4/OH

  • LPC.22.6 -4 -4 LPtdCho 22:6/OH

  • SM.34.1 -4 -4 SphMyelin (d18:1/16:0), SphMyelin (d18:0/16:1)

  • SM.36.1 -4 -4 SphMyelin (d18:1/18:0), SphMyelin (d18:0/18:1)

  • SM.36.2 -4 -4 SphMyelin (d18:1/18:1)

  • SM.42.1 -4 -4 SphMyelin (d18:1/24:0)

  • SM.42.2 -4 -4 SphMyelin (d18:1/24:1)

  • update_stamp -4 -4 -4

See also

https://adni.bitbucket.io/reference/docs/ADMCPDIPESIPCISRATIOS/ADMC_DMC_Phenomenome_Phosphatidylcholine_Lysophosphatidylcholine_Flow_Injection_Negative_Ionization_LC-MS-MS_Protocol.pdf, https://adni.bitbucket.io/reference/docs/ADMCPDIPESIPCISRATIOS/ADMC_Phenomenome_Phosphatidylethanolamine_Plasmenylethanolamine_Flow_Injection_LC-MS-MS_Protocol.pdf

Examples

if (FALSE) {
describe(admcpdipesipcisratios)
}